Jeeva and Vistatec Collaborate to Advance Multilingual Clinical Trials

Square

Vistatec, a global leader in AI, content, and localization solutions, is pleased to announce a new integration with Jeeva Clinical Trials, a recognized company offering AI-driven unified clinical‑trial management systems (CTMS). This integration supports life sciences teams aiming to ensure representation in clinical trials with multilingual patient screening and recruitment, digital patient engagement, and decentralized clinical trials to enable rural and remote patients to participate in clinical trials.

With localization built into Jeeva’s study design workflows, sponsors, sites, contract research organizations (CROs), and patients can now collaborate in real-time in their native language. Whether it’s educational content, electronic informed consent forms, medication diaries, symptom trackers, site instructions, or digital communications, the solution supports fast localization across 100+ languages, all within a secure, compliant environment.

“This is about meeting the growing demand for high-quality, localized clinical trial materials with speed and scale,” said Karen Tkaczyk, Director of Sales, Life Sciences at Vistatec. “We work with many forward-looking organizations across the life sciences ecosystem, and this integration with Jeeva is an example of how Vistatec can support efficient and representative trials through best-in-class language solutions.”

“Our mission has always been to democratize access to modern, patient‑centric research,” said Dr. Harsha K. Rajasimha, Founder & CEO of Jeeva Clinical Trials. By building Vistatec’s world‑class linguistic infrastructure directly into our platform’s DNA, we can help sponsors cut enrollment timelines by up to 30 percent and reach medically underserved populations without compromising compliance or quality.”

The collaboration reflects a broader industry shift. With rising global enrollment, innovative trial designs, decentralized trial models, and increasing regulatory focus on representation, multilingual readiness is now a critical success factor. According to recent guidance from the FDA and EMA, ensuring patients receive trial information in their native language is essential to improving access and representation in clinical research.

Addressing Real-World Needs in Clinical Research

The integrated workflow combines Jeeva’s no-code trial builder with Vistatec’s AI-accelerated language technology and certified in-country linguists. The result is a faster, more reliable way to localize clinical trial content:

  • Language-ready study design tools reduce rework and manual file handling
  • ISO 17100-certified quality processes ensure accuracy and audit readiness
  • Secure portals support multilingual eConsent, diaries, and communications
  • Version-controlled updates help keep study content aligned across markets

For study teams, this means trials can be configured and launched with multilingual components from the start. This greatly reduces the risk of costly amendments or delays related to language gaps.

A Growing Ecosystem

The Vistatec team works with numerous life sciences clients across therapeutic areas, geographies, and technology platforms. This integration represents one of many ways we support the evolving needs of the industry, whether through CTMS tools, patient communications, regulatory documentation, or global marketing initiatives.

To explore how Vistatec supports multilingual content for global clinical trials, contact our Life Sciences team or visit https://vistatec.com/life-sciences-division/ 


About Jeeva Clinical Trials

Jeeva Clinical Trials provides a cloud‑native, AI‑driven CTMS that accelerates study start‑up, streamlines global site operations, and empowers truly patient‑centric research. Its unified or modular approach lets sponsors deploy eConsent, ePRO, EDC, tele‑visits, trial scheduling, and digital patient engagement in less than four weeks while achieving compliance with FDA 21 CFR Part 11, GCP, GDPR, SOC2, and HIPAA. Learn more at https://jeevatrials.com.

About Vistatec

Vistatec delivers expert global content solutions that align precisely with your specific business needs.  Our expertise in bespoke language solutions spans multiple industries. We support many of the world’s most iconic brands to optimize their global commercial potential. Vistatec, established in 1997, is one of the world’s leading localization and content services providers, headquartered in Dublin, Ireland, with operations worldwide. Learn more at: www.vistatec.com